79383070 - ZYTOLIGHT

Information

  • Trademark
  • 79383070
  • Serial Number
    79383070
  • Registration Number
    7583067
  • Filing Date
    October 12, 2023
    a year ago
  • Registration Date
    December 03, 2024
    5 months ago
  • Transaction Date
    May 08, 2025
    4 days ago
  • Status Date
    December 03, 2024
    5 months ago
  • Published for Opposition Date
    October 01, 2024
    7 months ago
  • Location Date
    December 02, 2024
    5 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    BECKER, MARY
  • Attorney Docket Number
    61016.004U1
    Attorney Name
    Laurence P. Colton
  • Owners
Mark Drawing Code
4
Mark Identification
ZYTOLIGHT
Case File Statements
  • GS0051: Medical and veterinary preparations and articles in the nature of medical diagnostic reagents for diagnosis of genetic disorders and genetic aberrations in tumors; diagnostic preparations for medical use; diagnostic preparations for veterinary use; biological preparations for medical purposes, namely, DNA, RNA and oligonucleotide probes, being biochemical reagents, composed of biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for medical diagnostic purposes, namely, all for the treatment of genetic disorders and genetic aberrations in tumors; biological preparations for veterinary purposes, namely, DNA, RNA and oligonucleotide probes, being biochemical reagents, composed of biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for veterinary diagnostic purposes, namely, all for the treatment of genetic disorders and genetic aberrations in tumors; chemical preparations for medical purposes, namely, DNA probes, RNA probes and oligonucleotide probes, all being biochemical reagents composed of polynucleotides, biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for diagnosis of genetic disorders and genetic aberrations in tumors; chemical preparations for veterinary purposes, namely, DNA probes, RNA probes and oligonucleotide probes, all being biochemical reagents composed of polynucleotides, biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for diagnosis of genetic disorders and genetic aberrations in tumors; diagnostic chemical reagents for medical use; chemical preparations for testing blood for blood disorders, tumor diseases, viruses, bacteria, disease diagnosis and detection, organ function, metabolic disorders, endocrine disorders, hormonal disorders, bacteria-based disorders, virus-based disorders, fungal infections for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic chemical test reagents for medical purposes; diagnostic chemical test reagents for veterinary purposes; diagnostic agents for pharmaceutical use; diagnostic testing materials in the nature of diagnostic chemical and biological reagents for medical use; indicators for medical diagnosis in the nature of chemical and biological diagnostic reagents; clinical medical reagents; diagnostic reagents for medical use; reagents for use in diagnostic analysis for veterinary purposes; reagents for analytical diagnostic purposes for medical purposes; reagents for analytical diagnostic purposes for veterinary purposes; diagnostic reagents for in-vitro laboratory use for medical purposes; diagnostic reagents for in-vitro laboratory use for veterinary purposes; reagents for use in diagnostic tests for veterinary purposes; diagnostic reagents for microbiological analysis for medical purposes; diagnostic reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic analysis for medical purposes; reagents for use in diagnostic tests for medical purposes; diagnostic reagents for use with analyzers for veterinary purposes; diagnostic reagents for use with analyzers for medical purposes; reactants for medical diagnosis; reactants for veterinary diagnosis; veterinary diagnostic reagents
Case File Event Statements
  • 11/9/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC
  • 11/17/2023 - a year ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/14/2023 - a year ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 11/21/2023 - a year ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 5/30/2024 - 11 months ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/30/2024 - 11 months ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/14/2024 - 11 months ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/25/2024 - 10 months ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 8/22/2024 - 8 months ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/22/2024 - 8 months ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/22/2024 - 8 months ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/29/2024 - 8 months ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 8/29/2024 - 8 months ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 8/29/2024 - 8 months ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/29/2024 - 8 months ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 8/29/2024 - 8 months ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/11/2024 - 8 months ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/25/2024 - 10 months ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/27/2024 - 9 months ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/1/2024 - 7 months ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/1/2024 - 7 months ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/3/2024 - 5 months ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/3/2024 - 5 months ago
    23 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 4/8/2025 - a month ago
    26 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 4/26/2025 - 16 days ago
    27 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 5/6/2025 - 6 days ago
    29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 5/6/2025 - 6 days ago
    28 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 4/8/2025 - a month ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 3/3/2025 - 2 months ago
    24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR